Clients
Optibiotix Health Plc
OptiBiotix Health plc (AIM: OPTI) develops compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.
Management will hold the company’s AGM on 8 August 2024
Please check here for more information: https://www.londonstockexchange.com/news-article/OPTI/final-results/16541766
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results | 28 June |
| Interim Results* | September |
| AGM | 8 August |
* Months based on previous announcements of this kind
OPTI IMC May 2024
OPTI Company Summary April 2025
Who We Work With
Optibiotix Health Plc
OptiBiotix Health plc (AIM: OPTI) develops compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.
Management will hold the company’s AGM on 8 August 2024
Please check here for more information: https://www.londonstockexchange.com/news-article/OPTI/final-results/16541766
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results | 28 June |
| Interim Results* | September |
| AGM | 8 August |
* Months based on previous announcements of this kind
OPTI IMC May 2024
OPTI Company Summary April 2025
Leave a comment